#biontech
#biontech

[ follow ]

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute - MedCity News

BioNTech's acquisition of CureVac represents a strategic move to mitigate legal risks while combining their mRNA capabilities to enhance cancer treatment development.

NYC startup

London startup

fromwww.independent.co.uk

1 month ago

Vaccine maker's 1bn UK investment to create hundreds of high-skilled jobs'

BioNTech's investment will significantly enhance the UK's life sciences sector by creating jobs and fostering research.

Intellectual property law

fromIPWatchdog.com | Patents & Intellectual Property Law

3 months ago

Moderna COVID Vaccine Technology Struck Down by PTAB

Moderna's COVID-19 vaccine patents faced invalidation due to claims of being overly broad and prior knowledge of key vaccine concepts.

[ Load more ]

#biontech#biontech

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute - MedCity News

Vaccine maker's 1bn UK investment to create hundreds of high-skilled jobs'

Moderna COVID Vaccine Technology Struck Down by PTAB

#biontech
#biontech